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Abstract
Background. Poor transition planning contributes to discontinuity of care at the child–adult
mental health service boundary (SB), adversely affecting mental health outcomes in young
people (YP). The aim of the study was to determine whether managed transition (MT)
improves mental health outcomes of YP reaching the child/adolescent mental health service
(CAMHS) boundary compared with usual care (UC).
Methods. A two-arm cluster-randomised trial (ISRCTN83240263 and NCT03013595) with
clusters allocated 1:2 between MT and UC. Recruitment took place in 40 CAMHS (eight
European countries) between October 2015 and December 2016. Eligible participants were
CAMHS service users who were receiving treatment or had a diagnosed mental disorder,
had an IQ⩾ 70 and were within 1 year of reaching the SB. MT was a multi-component
intervention that included CAMHS training, systematic identification of YP approaching
SB, a structured assessment (Transition Readiness and Appropriateness Measure) and sharing
of information between CAMHS and adult mental health services. The primary outcome was
HoNOSCA (Health of the Nation Outcome Scale for Children and Adolescents) score
15-months post-entry to the trial.
Results. The mean difference in HoNOSCA scores between the MT and UC arms at
15 months was −1.11 points (95% confidence interval −2.07 to −0.14, p = 0.03). The cost
of delivering the intervention was relatively modest (€17–€65 per service user).
Conclusions. MT led to improved mental health of YP after the SB but the magnitude of the
effect was small. The intervention can be implemented at low cost and form part of planned
and purposeful transitional care.
Introduction
Transition from paediatric to adult care is problematic in many health specialities, but most
severe, complex and challenging in mental health care (Singh, Anderson, Liabo, &
Ganeshamoorthy, 2016). It should be a planned and purposeful process which addresses
the needs of young people (YP) as they move to adult services and towards independence
(Paul et al., 2013). Previous studies suggest that transition is ‘poorly planned, poorly executed,
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and poorly experienced’ (Singh et al., 2010). Many YP experience
discontinuity or disengagement from care on reaching the child–
adult mental health service boundary (SB) (Appleton, Connell,
Fairclough, Tuomainen, & Singh, 2019; Leavey et al., 2019;
Singh et al., 2010), with potentially adverse impact on their health
and wellbeing (Davis, Koroloff, Sabella, & Sarkis, 2018). Barriers
to optimal transition between child/adolescent mental health ser-
vice (CAMHS) and adult mental health service (AMHS),
although well-documented, are complex to overcome (Hovish,
Weaver, Islam, Paul, & Singh, 2012). Core elements needed to
improve transition are implementing policy, tracking and moni-
toring transition readiness, transition planning, transfer of care,
and completion (Cleverley, Rowland, Bennett, Jeffs, & Gore,
2020; Singh et al., 2016). There is as yet no standardised, shared
or robustly tested model of transitional care in the published lit-
erature (Singh et al., 2016; Tuomainen, Appleton, & Singh, 2020).
MILESTONE was an eight-country 5-year EU-funded project to
improve the experiences of YP at the child/adolescent to AMHS
interface (Tuomainen et al., 2018). The project comprised of
nine distinct but inter-related work packages, which have been
described elsewhere (Singh et al., 2017; Tuomainen et al., 2018).
We created a Transition Readiness and Appropriateness
Measure (TRAM) (Santosh et al., 2020b), which systematically
identifies the needs, preferences and readiness of YP for ongoing
adult care, including those who can be appropriately discharged.
Based on the TRAM, we developed a model of transitional care,
managed transition (MT) (online Supplementary Fig. S1)
(Singh et al., 2017). We conducted a cluster-randomised trial to
assess the effect of MT on mental health outcomes of YP
approaching the SB of their CAMHS compared with usual care




We conducted an eight-country, two-arm, parallel design, super-
iority, cluster-randomised controlled trial (cRCT) to assess
whether MT improves mental health outcomes in YP approach-
ing the CAMHS SB, compared to UC. The cRCT with economic
evaluation was embedded within the MILESTONE longitudinal
study (ISRCTN83240263 and NCT03013595), described else-
where and funded by the European Union (Singh et al., 2017).
Participating countries were Belgium, Croatia, France, Germany,
Ireland, Italy, Netherlands and the UK. The authors assert that
all procedures contributing to this study comply with the ethical
standards of the relevant national and institutional committees on
human experimentation and with the Helsinki Declaration of
1975, as revised in 2008. All procedures involving human subjects
were approved in the UK by the National Research Ethics Service
Committee West Midlands – South Birmingham (15/WM/0052)
and equivalent ethics boards in the participating countries. The
study protocol has been published (Singh et al., 2017).
Trial setting, eligibility and participants
Participating CAMHS were organisations delivering medical and
psychosocial interventions for children/adolescents with mental
health and/or neuropsychiatric/developmental disorders. Services
could be publicly or privately funded but had to have a formal
upper age limit (the SB) for providing care. Forensic services
and highly specialised services were excluded. The child/adoles-
cent to adult mental health SB was typically 18 years but varied
according to local practice (online Supplementary Table S2).
Eligible participants were YP with a mental disorder defined by
DSM-IV-TR, DSM-5 or ICD 10/11, who were receiving
CAMHS care, with an IQ ⩾ 70 and within 1 year of reaching
CAMHS SB. Recruitment occurred between 1st October 2015
and 31st December 2016. Because transition decisions were some-
times made after the YP reached the SB, we amended the eligibil-
ity criteria (in April 2016) to include YP who were up to
3-months older than the SB.
Participants were identified by clinicians, and other care staff,
and recruited by local study personnel. The YP’s parent (legal
guardian, a partner, an older adult sibling or another individual)
was also invited to participate, provided the young person agreed.
Written informed consent was obtained from all participants. For
YP below the age of consent (UK <16, Europe <18), a parent/legal
guardian was required to provide consent, with the YP signing an
assent form. YP involved in the study were offered incentives as
‘token of thanks’ for participating. Incentives were shopping vou-
chers (in all countries but Italy and Croatia) and/or being entered
into a prize draw (Singh et al., 2017). Further details of method-
ology and design have been reported elsewhere (Singh et al.,
2017).
Randomisation and masking
Clusters were individual CAMHS recruited to the MILESTONE
study (cRCT, economic evaluation and longitudinal cohort
study) (Singh et al., 2017). Randomisation (2:1 between UC and
MT) was undertaken in two stages and stratified by country to
ensure that the number of clusters per country was divisible by
3 and that all countries had both control and intervention clus-
ters. It was not feasible to blind clinicians or the research team,
but YP and parents/carers were informed of trial arm, only if
requested, after consenting to participate.
Trial interventions
MT (online Supplementary Fig. S1) was a multi-component inter-
vention that included CAMHS training, systematic identification
of YP approaching SB, a structured assessment (TRAM) and feed-
back of the TRAM findings to the CAMHS clinician (via the
TRAM summary report). Prior to opening to recruitment,
CAMHS clinicians at the intervention sites were invited to a single
standardised training session on good/effective transition and
interpretation of the TRAM summary report. Once the TRAM
summary report relating to a participant (online Supplementary
Fig. S2) was ready, it was sent to the CAMHS clinician along
with a letter advising that it should be discussed with the YP
and parent/carer and attached to any referral letter to AMHS
(online Supplementary Fig. S3). To reinforce the learning under-
taken during training, a leaflet reminding the CAMHS clinician
why care in transition is important, and what YP say helps
them with transition, was also included (online Supplementary
Fig. S4). Clinicians in the UC group did not receive the TRAM
summary report or any training regarding transition.
Data collection
Outcomes were assessed at baseline, 9 months and 15 months
using structured interviews (by research assistants not blinded
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to group membership) and self-reported measures (online
Supplementary Table S3). Data were collected via a web-based,
secure, data capture system (HealthTracker™). Interviews to com-
plete the Health of the Nation Outcome Scale for Child and
Adolescents (HoNOSCA) were held at the CAMHS, the partici-
pant’s home, or an alternative location (according to the partici-
pant’s preference). Participants were asked to complete other
measures within 2 weeks of the HoNOSCA interview but were
allowed a 3-month window.
Outcomes
Primary outcome
The primary outcome was HoNOSCA score 15-months post-
entry to the trial (Garralda, Yates, & Higginson, 2000; Gowers
et al., 1999). This validated and internationally widely implemen-
ted global outcome measure for child/adolescent mental health
care includes domains of symptoms, behaviour, impairments and
social functioning (Harris et al., 2018). Items 1–13 are scored on a
scale of 0–4 (0 indicates no problem, 4 severe problem; a detailed
glossary describes scales for each item) (Ballesteros-Urpí et al.,
2018; Harris et al., 2018). The total score, indicating the severity
of the mental health problem/s, is the sum of the 13 items.
HoNOSCA was completed by a trained Research Assistant follow-
ing semi-structured interviews with the young person, and (where
possible) with parent/carer and relevant clinician (or review of
medical records if the relevant clinician was not available).
Secondary outcomes
Secondary outcomes were self-reported HoNOSCA score
(HoNOSCA-SR) (Gowers, Levine, Bailey-Rogers, Shore, &
Burhouse, 2002), transition outcomes (TROM) (Santosh et al.,
2020a), quality of life (WHOQOL-BREF) (Skevington, Lotfy, &
O’Connell, 2004), functioning and impairment (SLOF) (Mucci
et al., 2014), self-reported emotional/behaviour problems (YSR/
ASR) (Achenbach & Rescorla, 2001), parent/carer reported emo-
tional/behavioural problems (CBCL/ABCL) (Achenbach &
Rescorla, 2003), independent behaviour (IBDCS) (van Staa,
2011), illness severity (CGIS) (Guy, 1976), transfer experience
(OYOF-TES) (van Staa & Sattoe, 2014), health-related quality of
life (EQ-5D-5L) (Herdman et al., 2011) and resource utilisation
(CSRI) (Chisholm et al., 2000). Further details on outcome mea-
sures are given in online Supplementary Table S4. Information
on YP’s referral and transition status was collected from their
CAMHS clinician. Information on severe adverse events (SAEs)
was collected, specifically self-harm, suicidal thoughts, suicide
through physical harm or with drugs, or death.
Statistical analysis
Assuming an average cluster size of 15 participants, an allocation
ratio of 2:1 (control:intervention), a coefficient of variation of clus-
ter size of 0.4 (cluster size ranging from 5 to 30), and an
intra-cluster correlation coefficient of 0.01, we estimated that with
600 participants [195 intervention arm (13 clusters), 405 control
arm (27 clusters)] the trial would have 89% power to detect a dif-
ference of 0.30 standard deviations (S.D.s) in the primary outcome
measure (HoNOSCA). Allowing for 30% attrition, we aimed to
recruit 21 participants per cluster. The target sample size was,
therefore, 840 participants in total (273 intervention; 567 control).
We tested the null hypothesis of no difference in mean
HoNOSCA score between the MT and UC groups at month 15
post-randomisation, using a generalised linear mixed effect
model (GLMM) with random and fixed effects (to allow for the
hierarchical structure of the data and adjust for trial arm, time
point and baseline characteristics, HoNOSCA score, gender and
diagnosis). Secondary outcomes HoNOSCA-SR and quality of
life (WHOQOL-BREF) were analysed using a hierarchical linear
mixed model with random effects for the four levels (country,
site, participant and follow-up time) and adjustment for the
same fixed effects. For other secondary outcomes, descriptive ana-
lyses were conducted. The significance level was set at 5%, with no
adjustment for multiple testing. All analyses were on an
intention-to-treat basis and followed a pre-specified statistical
analysis plan (available at https://www.milestone-transitionstudy.
eu/).
To examine the cost of implementing the intervention, clini-
cians were invited to complete a questionnaire on the time burden
of completing TRAM. Time spent by the Warwick team prepar-
ing and checking TRAM reports was also recorded. We also cap-
tured the resources required to set up the intervention and
conduct initial training of clinicians. Resource use data were com-
bined with unit cost data (see online Supplementary appendix,
‘Intervention costing’) to estimate intervention costs.
All analyses were conducted using Stata 16 (StataCorp, 2019).
Results
Participants
Participant flow through the trial, including numbers screened,
numbers recruited, withdrawals and loss to follow-up are shown
in Fig. 1. In all, 844 YP were recruited (1st Oct 2015–31st Dec
2016) from 40 CAMHS, including 19 YP who withdrew before
baseline assessment. A further 32 participants (at a single site
in Croatia) were excluded owing to uncertainty concerning valid-
ity of participant consent, so 793 were available for the baseline
assessments [Table 1 (abridged), online Supplementary Table S1
(full version)]; 273 in the MT group and 552 in the UC group.
Attrition rates at 15 months were similar in the trial arms (4%
UC group; 5% MT group). Reasons for withdrawal, where
given, were similar in both trial arms – mainly being too busy
and not wanting to talk about mental health problems. Online
Supplementary Fig. S5 is a CONSORT diagram illustrating the
number and sizes of clusters (CAMHS) recruited and randomised
to the MILESTONE study (cRCT, economic evaluation and lon-
gitudinal cohort study). Further information about participating
CAMHS (whether community and/or hospital based, existence
of transition policy and means of funding) is given in online
Supplementary Table S2. Baseline demographic and clinical char-
acteristics of participants were generally well-balanced between
the trial arms except that YP in the MT group were slightly
more unwell (as shown by the HoNOSCA, TRAM and CGI
scores, Table 1). Baseline characteristics of other participants
(parent/carers, CAMHS and AMHS clinicians) are given by
trial arm in online Supplementary Tables S5–S7.
Transition decisions
To inform transition decisions, 219 TRAM summary reports were
produced for clinicians in the MT arm, relating to 91% of the YP
in that group. At 15 months follow-up, 26.5% of participants were
still under the care of their original CAMHS (27.4% UC v. 24.5%
MT) (online Supplementary Table S8). Clinicians in the MT
Psychological Medicine 3
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group recommended continuing in CAMHS slightly more fre-
quently than in the UC group (25.0% UC v. 28.6% MT) and
also transition to AMHS (21.0% UC v. 27.0% MT). Slightly
more YP had been accepted by, and were under the care of,
their new service at 15 months follow-up in the MT group com-
pared to UC (22.1% UC v. 28.2% MT). The number of YP
rejected by or not yet seen by the new service was small (0.54%
UC v. 1.2% MT). In the MT group, 35.3% of clinicians reported
sharing, or intending to share, the TRAM findings with the young
person, despite the fact this was not a requirement of the inter-
vention. Similarly, a very small number of CAMHS clinicians in
the UC group (3.44%) also reported having shared, or intending
to share, the TRAM findings with the young person but as they
did not receive the TRAM summary report, these responses
Fig. 1. Participant flow through the trial.
4 S. P. Singh et al.
https://doi.org/10.1017/S0033291721003901
Downloaded from https://www.cambridge.org/core. IP address: 84.64.168.154, on 03 Nov 2021 at 11:37:41, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
Table 1. Baseline characteristics of participants (abridged versiona)
UC (n = 552) MT (n = 241) Total (n = 793)
Age (mean, S.D.) 17.48 (0.59) 17.64 (0.51) 17.53 (0.57)
Number (%) age unknown 5 (0.91%) 3 (1.25%) 8 (1.01%)
Gender (N, %)
Female 340 (61.59%) 149 (61.83%) 489 (61.66%)
Male 211 (38.22%) 90 (37.34%) 301 (37.69%)
Prefer not to say 1 (0.18%) 2 (0.83%) 3 (0.38%)
Ethnicity (N, %)
White 450 (81.52%) 210 (87.14%) 660 (83.23%)
Middle Eastern 1 (0.18%) 1 (0.41%) 2 (0.25%)
Asian 5 (0.91%) 7 (2.90%) 12 (1.51%)
Black/African/Caribbean 7 (1.27%) 4 (1.66%) 11 (1.39%)
Central or South American 6 (1.09%) 2 (0.83%) 8 (1.01%)
Mixed 12 (2.17%) 1 (0.41%) 13 (1.64%)
Unknown/Unspecified 71 (12.86%) 16 (6.64%) 87 (10.97%)
Country (N, %)
Belgium 64 (11.57%) 33 (13.69%) 97 (12.23%)
Croatia 52 (9.42%) 0 (0.00%)b 52 (6.56%)
France 66 (11.93%) 13 (5.39%) 79 (9.96%)
Germany 64 (11.57%) 45 (18.67%) 109 (13.75%)
Ireland 12 (2.17%) 9 (3.73%) 21 (2.65%)
Italy 127 (22.97%) 63 (26.14%) 190 (23.96%)
Netherlands 75 (13.56%) 43 (17.84%) 118 (14.88%)
United Kingdom 92 (16.67%) 35 (14.52%) 127 (16.02%)
Primary clinical diagnosis (N, %)
Substance-related and addictive disorders 3 (0.54%) 9 (3.73%) 12 (1.51%)
Schizophrenia spectrum and other psychotic disorders 26 (4.71%) 1 (0.41%) 27 (3.40%)
Depressive, bipolar and related disorders 104 (18.84%) 60 (24.90%) 164 (20.68%)
Anxiety disorders 69 (12.50%) 25 (10.37%) 94 (11.85%)
Obsessive-compulsive and related disorders 14 (2.54%) 4 (1.66%) 18 (2.27%)
Trauma- and stressor-related disorders 21 (3.80%) 24 (9.96%) 45 (5.67%)
Dissociative disorders 0 (0.00%) 1 (0.41%) 1 (0.13%)
Somatic symptoms and related disorders 9 (1.63%) 2 (0.83%) 11 (1.39%)
Feeding and eating disorders 45 (8.15%) 9 (3.73%) 54 (6.81%)
Disorders of adult personality and behaviour 24 (4.35%) 11 (4.56%) 35 (4.41%)
Gender dysphoria 4 (0.72%) 2 (0.83%) 6 (0.76%)
Other disorders of adult personality and behaviour 1 (0.18%) 0 (0.00%) 1 (0.13%)
Neurodevelopmental disordersc 186 (33.70%) 71 (29.46%) 257 (32.41%)
Otherd 3 (0.54%) 1 (0.41%) 4 (0.50%)
Unspecified/other mental disorder 2 (0.36%) 2 (0.83%) 4 (0.50%)
Multiple primary diagnoses 21 (3.80%) 9 (3.73%) 30 (3.78%)
None 20 (3.62%) 10 (4.15%) 30 (3.78%)
Time spent under CAMHS care (N, %)
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Table 1. (Continued.)
UC (n = 552) MT (n = 241) Total (n = 793)
6 months to 1 year 90 (16.30%) 42 (17.43%) 132 (16.65%)
1 year to 2 years 91 (16.49%) 30 (12.45%) 121 (15.26%)
2 years to 5 years 145 (26.27%) 57 (23.65%) 202 (25.47%)
5 to 10 years 76 (13.77%) 37 (15.35%) 113 (14.25%)
More than 10 years 49 (8.88%) 17 (7.05%) 66 (8.32%)
Unknown 49 (8.88%) 15 (6.22%) 64 (8.07%)
HoNOSCA (mean, S.D.) 11.60 (6.86) 13.78 (7.11) 12.14 (6.98)
Number missing (%) 23 (4.17%) 12 (4.98%) 35 (4.41%)
HoNOSCA Self Report (SR) (mean, S.D.) 12.26 (9.23) 12.72 (8.33) 12.40 (8.96)
Number missing (%) 39 (7.07%) 15 (6.22%) 54 (6.81%)
TRAM (clinician report)
Subscales (mean, S.D.)
Symptoms 17.74 (9.97) 21.23 (9.95) 18.85 (10.09)
Risk 14.70 (12.50) 20.11 (13.06) 16.42 (12.92)
Overall disruption 24.89 (18.40) 26.28 (15.97) 25.33 (17.67)
Factors affecting symptoms 23.86 (18.59) 27.40 (20.26) 24.99 (19.20)
Barriers to functioning 26.12 (14.20) 27.77 (13.58) 26.64 (14.02)
Overall illness (takes into account all symptoms across all existing conditions) (N, %)
Recovered – ongoing treatment not required 59 (10.69%) 24 (9.96%) 83 (10.47%)
Recovered – symptoms absent as long as on treatment 80 (14.49%) 22 (9.13%) 102 (12.86%)
Mildly ill 102 (18.48%) 45 (18.67%) 147 (18.54%)
Moderately ill 142 (25.72%) 84 (34.85%) 226 (28.50%)
Severely ill 77 (13.95%) 41 (17.01%) 118 (14.88%)
Very severely ill 7 (1.27%) 3 (1.24%) 10 (1.26%)
Unknown 85 (15.40%) 22 (9.13%) 107 (13.49%)
Number (%) YP with no TRAM CR at T1 85 (15.40%) 22 (9.13%) 107 (13.49%)
WHO Quality of Life Brief Inventory (WHOQOL-BREF) (mean, S.D.)
Physical health 14.84 (2.66) 14.41 (2.93) 14.71 (2.75)
Psychological 12.20 (3.56) 11.83 (3.57) 12.09 (3.57)
Social relationships 13.72 (3.31) 13.99 (3.36) 13.80 (3.33)
Environment 15.15 (2.64) 14.86 (2.52) 15.06 (2.60)
Number (%) missing 48 (8.70%) 26 (10.79%) 74 (9.33%)
EQ-5D-5L (health status) (mean, S.D.) 0.78 (0.20) 0.78 (0.20) 0.78 (0.20)
Number (%) missing 47 (8.51) 25 (10.37) 72 (9.08)
Youth Self Report (YSR), Adult Self Report (ASR) (t scores) (mean, S.D.)
Internalising problems 60.62 (12.56) 63.42 (12.73) 61.47 (12.67)
Externalising problems 51.54 (10.61) 53.64 (9.67) 52.18 (10.37)
Number (%) missing 55 (9.96) 24 (9.96) 79 (9.96)
Child Behaviour Checklist (CBCL), Adult Behaviour Checklist (ABCL) (t scores) (mean, S.D.)
Internalising problems 63.62 (10.90) 65.81 (10.42) 64.24 (10.80)
Externalising problems 53.75 (10.23) 57.15 (10.67) 54.72 (10.47)
Number (%) missing 137 (24.82) 75 (31.12) 212 (26.73)
Severity of illness (CGI)
(Continued )
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must (if not reporting errors) refer to the clinician version of the
TRAM and may therefore indicate contamination.
Primary outcome
Unadjusted mean HoNOSCA scores differed significantly
between the MT and UC groups at baseline and at 15 months,
and declined over time in both groups (online Supplementary
Fig. S6). This indicated general improvement in mental health
and wellbeing over time in both groups but the reduction
appeared more rapid in the MT group (online Supplementary
Fig. S7). The difference in mean HoNOSCA scores between the
trial arms (MT-UC) at 15 months, estimated by the GLMM,
was −1.11 [95% confidence interval (CI) −2.07 to −0.14, p =
0.03] (Table 2). The difference between the UC and MT trial
arms in the rate of change in the HoNOSCA score over the
study period (baseline to 15 months) was −1.70 (95% CI −2.97
to −0.43, p = 0.009). The intraclass-correlation coefficient between
HoNOSCA scores in the same country was 0.004 (95% CI 0.000–
0.782), between HoNOSCA scores in the same cluster and coun-
try was 0.037 (95% CI 0.018–0.076) and between HoNOSCA
scores in the same participant, cluster and country was 0.110
(95% CI 0.068–0.173). Country, cluster and individual
random-effects accounted for only 12.3% of the total residual
variation. The results of sensitivity, subgroup and exploratory
analyses of the primary outcome are presented in the online
Supplementary appendix (Figs S8 and S9).
Secondary outcomes
After adjusting for HoNOSCA-SR at entry, gender, clinical diag-
nosis and clustering, the difference in mean HoNOSCA-SR scores
between the trial arms (MT-UC) at 15 months was −1.71 (95% CI
−2.88 to −0.55, p = 0.004) (Table 2). There was no significant dif-
ference in the quality of life ratings (WHO-BREF) between the
trial groups at 15 months (after adjusting for clustering, baseline
WHO-BREF score, gender and clinical diagnosis). Other second-
ary outcomes are summarised in Table 3. As these data have not
been adjusted to account for clustering and imbalances in clinical
and demographic factors at baseline, they should be interpreted
cautiously. There were no marked differences between the UC
and MT groups for the majority of measures [IBDCS, YSR/
ASR, CBCL/ABCL, number of life events, CGIS, EQ-5D, SLOF,
OYOF-TES (YP), OYOF-END (YP), OYOF-END (PC) and
TROM] but parents/carers of YP who were to transition to
AMHS did report satisfaction with end of care, and satisfaction
with preparation for end of care, slightly more often in the MT
group than with UC group (38.6% v. 35.5% and 40.2% v.
37.8%, respectively). There was no difference in overall satisfac-
tion between these groups, however, with parent/carers in both
groups reporting fairly high levels of satisfaction overall (average
scores were 7/10 on a 0–10 scale, where 0 indicates completely
unsatisfied and 10 fully satisfied).
Self-harm (suicide, suicide attempt and suicidal thoughts) was
the most common serious adverse event (online Supplementary
Table S9). None were assessed to be related to participation or
the intervention, and there was no difference in pattern, severity
or frequency of SAEs between trial arms.
The intervention was relatively inexpensive to implement, with
direct intervention delivery costs ranging between €17 and €65
per child and clinician training costs ranging between €22 and
€176, depending on how training and delivery was conducted
in each country.
Discussion
This is the first-ever RCT of a scalable intervention for improving
mental health outcomes for YP at the child–adult SB. We met our
original recruitment target and retention of participants was better
than expected: 15-month primary outcome was assessed in 76%
(602/793) of the cohort across eight countries. Overall, the trial cov-
ered 38 child/adolescent services in eight European countries mak-
ing the study findings generalisable to a range of settings.
We developed and tested a new intervention, MT, in eight
European countries (Singh et al., 2017). Our model, based on
available evidence (Paul, Street, Wheeler, & Singh, 2015), includes
structured assessments of transition need, readiness and appropri-
ateness, and facilitated shared decision-making between YP, par-
ent/carer, CAMHS clinician and, where appropriate, with AMHS
clinicians. The intervention uses relatively few resources, is easily
incorporated into routine clinical practice and is generalisable to
scale. We found that compared to UC, MT led to a small
Table 1. (Continued.)
UC (n = 552) MT (n = 241) Total (n = 793)
Not assessed (0) 13 (2.36%) 5 (2.07%) 18 (2.27%)
Normal, not at all ill (1) 33 (5.98%) 12 (4.98%) 45 (5.67%)
Borderline mentally ill (2) 75 (13.59%) 30 (12.45%) 105 (13.24%)
Mildly ill (3) 114 (20.65%) 44 (18.26%) 158 (19.92%)
Moderately ill (4) 128 (23.19%) 70 (29.05%) 198 (24.97%)
Markedly ill (5) 73 (13.22%) 45 (18.67%) 118 (14.88%)
Severely ill (6) 34 (6.16%) 11 (4.56%) 45 (5.67%)
Among the most extremely ill patients (7) 6 (1.09%) 3 (1.24%) 9 (1.13%)
Unknown 76 (13.77%) 21 (8.71%) 97 (12.23%)
aFor full baseline characteristics see online Supplementary Table S1.
bWe randomised three clusters from Croatia (two to the UC arm and one to MT) but had to withdraw one of the clusters (MT arm) from the study due to uncertainty regarding the validity of
participant consent. The data collected from this site are therefore excluded from the analysis.
cIncludes 42 with specific learning disorders (36 UC, 6 MT), 74 with autism (56 UC, 18 MT) and 97 with ADHD (69 UC, 28 MT).
dIncludes relational problems and other circumstances of personal history.
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improvement in overall mental health and wellbeing of YP 15
months after entry to the trial. Furthermore, improvement was
more rapid than with UC.
Our MT model ensures that the process of transition is
planned and purposeful, and addresses the needs of YP as they
reach the upper age SB and move towards independence (Paul
et al., 2013). In our model, young person and their carer are
closely involved in preparation for leaving one service and joining
another, with adequate information sharing and a service align-
ment to maintain therapeutic continuity (Cleverley et al., 2020;
Singh et al., 2016). Our model of MT is relatively easy to imple-
ment: data collation can be fully automated within a web-based
platform and incorporated into routine care. The paper-version
of the TRAM is available in seven languages and is free of charge
to charities and publicly funded organisations (requests to corre-
sponding author). Although the need for such a model has often
ben articulated, our study shows that transition process can be
improved with modest investment of time and resources.
TRAM and the MT model may also lend themselves, with appro-
priate modifications, to other clinical settings and disciplines
where transition between services is unsatisfactory (Hart,
Patel-Nguyen, Merkley, & Jonas, 2019).
Previous attempts at improving service transition in mental
health are few, and no RCT has ever been conducted (Appleton
et al., 2019; Paul et al., 2015). A recent study used a ‘shared man-
agement model’ with individualised transitional care plans and a
transition coordinator (Cappelli et al., 2016) and another a stream-
lined transition process for YP in an attention deficit hyperactivity
disorder transition clinic (Moosa & Sandhu, 2015). Both reduced
the number of YP waiting for a referral and improved access to
AMHS, but did not measure mental health outcomes after transi-
tion. Another recent innovation is extending the CAMHS bound-
ary beyond 18, such as in Australia (McGorry, Bates, &
Birchwood, 2013) and in the UK (Norfolk and Birmingham). In
Norfolk, UK, a redesigned 14–25 year service increased referrals
to the service, yet the proportion of accepted referrals dropped
(Maxwell et al., 2019). The 14–25 model also risks creating another
SB at 14. An evaluation of the 0–25 service in Birmingham, UK,
found that a shortage of medical staff, poor service infrastructure,
inadequate or incompatible data management systems, among
other things, hampered care provision despite widespread support
for the model (Birchwood et al., 2018).
Our MT model provides a solution that can be applied within
existing service structures. For more robust transitional health
care for YP, the MT model could be implemented as part of a
comprehensive package of service alignment. The MT model is
far less resource intensive than large-scale service reorganisation
such as the 0–25 model, multi-component transition-specific pro-
grammes, or youth-friendly service models (Hetrick et al., 2017;
McGorry et al., 2013). The overall service alignment should take
other aspects of transition into account (Cleverley et al., 2020;
Singh et al., 2016), including transition to non-mental health ser-
vices (Appleton et al., 2019).
The modest clinical gains of our trial need to be interpreted in
the context of the need for a single quantitative primary outcome
measure for a process-related study. Finding a suitable measure
for the primary outcome was difficult, owing to the nature of
the intervention and clinical diversity of the participants. We
decided on HoNOSCA because it was developed for child/adoles-
cent mental health care settings and is used widely in Europe
(Garralda et al., 2000; Harris et al., 2018). Baseline HoNOSCA
scores were low in the trial (mean = 12.14, S.D. = 6.98), in keeping
with comparative groups in the UK (mean = 13.71) (Gowers et al.,
1999) and Italy (mean = 13.6) (D’Avanzo et al., 2018). The reduc-
tion in the mean HoNOSCA score observed with MT (1.11
points) therefore corresponds to an approximate 9% relative
reduction in the HoNOSCA score, equivalent to each participant
having a 1 point reduction in symptom severity on 1–2 of the 13
questions (from moderately severe to mild, say, or from severe to
moderately severe).
We were surprised at the relatively large proportion of YP still
in CAMHS or without a transition decision at 15 months, but
similar findings have been confirmed in a recent systematic review
(Appleton et al., 2019). It perhaps reflects the diverse funding
structures across the EU, with CAMHS in some countries able
and willing to continue providing care beyond the SB (Signorini
et al., 2017, 2018). Discharge of YP who do not require transition
to AMHS may be challenging for CAMHS clinicians because
Table 2. Statistical analysis of primary and secondary outcomes 15 months after entry to the study
N (%)
UC (mean score at
15 months) (N = 552) N (%)
MT (mean score at
15 months) (N = 241) Difference and 95% CI p value
Primary outcome
HoNOSCA 429 (77.72) 8.82 (6.25) 173 (71.78) 8.63 (6.00) −1.11 (−2.07 to 0.14)a 0.03
Secondary outcomes
HoNOSCA SR 393 (71.20) 10.72 (8.91) 174 (72.20) 9.52 (7.35) −1.71 (−2.88 to 0.55)b 0.004
WHOQOL-BREF
Physical health 371 (67.21) 50.20 (13.21) 158 (65.56) 48.62 (10.99) −1.07 (−3.34 to 1.19)c 0.35
Psychological 371 (67.21) 51.22 (16.71) 158 (65.56) 51.03 (14.49) 0.91 (−2.15 to 3.97)c 0.56
Social relationships 371 (67.21) 62.92 (20.59) 158 (65.56) 62.03 (19.40) 1.28 (−2.76 to 5.32)c 0.54
Environment 371 (67.21) 67.92 (16.61) 158 (65.56) 67.25 (14.47) 1.27 (−1.83 to 4.36)c 0.42
aMean difference in the HoNOSCA score between the trial arms (MT–UC) at 15 months, from a multilevel model with four levels (country, site, participant and follow-up time) and adjustment
for gender, baseline HoNOSCA score and diagnosis (categorised as anxiety, depression, neurodevelopmental disorder or other).
bMean difference in HoNOSCA-SR score between the trial arms (MT–UC) at 15 months, from a multilevel model with four levels (country, site, participant and follow-up time) and adjustment
for gender, baseline HoNOSCA-SR score and diagnosis (categorised as anxiety, depression, neurodevelopmental disorder or other).
cMean difference in WHOQOL-BREF score between the trial arms (MT–UC) at 15 months, from a multilevel model with four levels (country, site, participant and follow-up time) and
adjustment for gender, baseline WHOQOL-BREF score and diagnosis (categorised as anxiety, depression, neurodevelopmental disorder or other).
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Table 3. Summary of other secondary outcomes 15 months after entry to the studya
N (%b) UC N (%c) MT
Independent Behaviour During Consultation Scale (mean, S.D.) 196 (35.51) 15.98 (6.76) 83 (34.44) 15.48 (5.78)
Number (%) missingd 356 (64.49) 158 (65.56)
Youth Self Report/Adult Self Report (YSR/ASR) (t scores)
Internalising problems 381 (69.02) 60.23 (14.62) 161 (66.81) 60.08 (13.05)
Externalising problems 381 (69.02) 51.24 (11.00) 161 (66.81) 51.05 (9.55)
Number (%) missing 171 (30.98) 80 (33.19)
Child Behaviour Checklist/Adult Behaviour Checklist (CBCL/ABCL) (t scores)
Internalising problems 310 (56.16) 58.94 (11.65) 110 (45.64) 58.89 (11.65)
Externalising problems 310 (56.16) 52.35 (9.24) 110 (45.64) 52.90 (9.10)
Number (%) missing 242 (43.84) 131 (54.36)
Number of life events [median (IQR)] 385 (69.75) 1 (0–2) 164 (68.05) 1 (0–2)
Number (%) missing 167 (30.25) 77 (31.95)
Severity of illness (CGIS)
Not assessed (0) 8 (1.45) 0 (0.00)
Normal, not at all ill (1) 9 (1.63) 7 (2.90)
Borderline mentally ill (2) 19 (3.44) 11 (4.56)
Mildly ill (3) 37 (6.70) 16 (6.64)
Moderately ill (4) 43 (7.79) 18 (7.47)
Markedly ill (5) 16 (2.90) 13 (5.39)
Severely ill (6) 11 (1.99) 4 (1.66)
Among the most extremely ill patients (7) 1 (0.18) 0 (0.00)
Unknowne 408 (73.91) 172 (71.37)
EQ-5D (mean, S.D.) 390 (70.65) 0.79 (0.21) 168 (69.71) 0.80 (0.21)
Number (%) missing 162 (29.35) 73 (30.29)
Specific Levels of Functioning Scale (SLOF) [median (IQR)]
Physical functioning 311 (56.34) 25 (24–25) 113 (46.89) 25 (24–25)
Personal care skills 311 (56.34) 35 (33–35) 113 (46.89) 35 (33–35)
Interpersonal relationships 311 (56.34) 28 (22–33) 113 (46.89) 27 (22–33)
Social acceptability 311 (56.34) 34 (31–35) 113 (46.89) 33 (32–35)
Activities 311 (56.34) 53 (49–55) 113 (46.89) 53 (49–55)
Work skills 311 (56.34) 26 (21–29) 113 (46.89) 24 (20–30)
Number (%) missing 241 (43.66) 128 (53.11)
On Your Own Feet – Transition Experience Scale (OYOF-TES)f (young person) (mean, S.D.)
Satisfaction with end of care 126 (22.83) 36.93 (8.57) 69 (28.63) 36.32 (8.64)
Preparation for end of care 126 (22.83) 32.67 (7.84) 69 (28.63) 31.90 (8.11)
Overall satisfaction (scale 0–10) 126 (22.83) 6.14 (2.85) 69 (28.63) 6.12 (2.54)
OYOF-ENDg (end of care) (young person) (mean, S.D.)
Satisfaction with end of care 202 (36.59) 18.35 (4.00) 82 (34.02) 19.29 (3.48)
Preparation for end of care 202 (36.59) 29.38 (7.46) 82 (34.02) 30.59 (7.37)
Overall satisfaction (scale 0–10) 202 (36.59) 6.98 (2.54) 82 (34.02) 6.95 (2.50)
OYOF-TESf (parent/carer) (mean, S.D.)
Satisfaction with end of care 97 (17.57) 35.53 (9.32) 58 (24.07) 38.57 (7.18)
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many primary care services feel under-resourced and poorly
equipped to meet the complex needs of these YP
(Tatlow-Golden, Prihodova, Gavin, Cullen, & McNicholas, 2016).
There are, as in any trial, limitations of this study. The most
unwell may be underrepresented; so we may have missed some
for whom transition is essential but particularly challenging. We
could not blind the CAMHS clinicians or assessors; the former
was unavoidable given the nature of the intervention, but the lat-
ter was imposed due to resourcing issues. Blinding of assessors
would have required two research assistants per recruitment
site: one to deal with training, recruitment and the administrative
aspects of the trial and another to undertake HoNOSCA inter-
views and assessments. This may also have made it more difficult
for our research assistants to bond with participants, as each par-
ticipant would now have two contacts within the research team to
develop a relationship with rather than one. For clinicians in the
UC arm, knowledge of the trial may have enhanced their focus on
transition options. Furthermore, although, clinicians in the UC
arm did not receive the TRAM summary report they did complete
the clinician version of the TRAM, which may also have influ-
enced their decision making.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291721003901
Data. Requests for original (fully anonymised) participant data may be made
to the corresponding author.
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